Moderna
MRNA
#1635
Rank
HK$99.46 B
Marketcap
HK$254.56
Share price
1.42%
Change (1 day)
-18.93%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025HK$50.54 M-67.66%
2024HK$0.15 B15.08%
2023HK$0.13 B-50.15%
2022HK$0.27 B-85.7%
2021HK$1.90 B158.2%
2020HK$0.73 B369.18%
2019HK$0.15 B1011.49%
2018HK$14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Regulus Therapeutics
RGLS
N/AHK$5.58 M๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$17.08 MHK$0.16 B๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$0.09 MHK$0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$8.65 MHK$41.99 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$19.76 MHK$75.6 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
HK$2.01 MHK$7.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$57.52 MHK$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA